Change in Trajectories of Adherence to Lipid‐Lowering Drugs Following Non‐Fatal Acute Coronary Syndrome or Stroke

BACKGROUND: Poor adherence to cardioprotective drugs remains a concern among patients for secondary prevention. A better understanding of adherence fluctuations before and after critical health events may inform approaches for addressing or preventing poor adherence. Therefore, we assessed trajector...

Descripción completa

Detalles Bibliográficos
Autores principales: Zongo, Arsène, Simpson, Scot, Johnson, Jeffrey A., Eurich, Dean T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912969/
https://www.ncbi.nlm.nih.gov/pubmed/31771443
http://dx.doi.org/10.1161/JAHA.119.013857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912969/
https://www.ncbi.nlm.nih.gov/pubmed/31771443
http://dx.doi.org/10.1161/JAHA.119.013857

Ejemplares similares